| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | -0.0071 | 1 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.003 | 1 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.00095 | 1 |